| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 脉血康胶囊(元) | 84,837,146.14 | 456,825,395.12 | 202,448,142.79 | 467,209,764.45 | 238,649,523.38 |
| 脉血康片剂(元) | 2,676,091.60 | 16,483,665.49 | 6,218,309.50 | 14,115,467.57 | 7,515,901.32 |
| 晕痛定胶囊(元) | 21,685,509.36 | 56,664,542.86 | 28,231,094.17 | 76,194,669.42 | 38,093,863.59 |
| 其他品种(元) | 37,174,892.84 | 14,153,099.62 | 5,253,744.13 | 18,776,241.60 | 6,785,199.30 |
| 营业成本(元) | |||||
| 脉血康胶囊(元) | 46,078,304.27 | 82,466,670.40 | 38,053,934.38 | 98,855,383.50 | 56,123,371.92 |
| 脉血康片剂(元) | 4,353,206.30 | 6,339,477.36 | 2,147,231.59 | 3,097,620.20 | 1,768,041.75 |
| 晕痛定胶囊(元) | 5,226,096.98 | 13,609,159.16 | 6,913,608.79 | 16,503,684.06 | 7,498,368.07 |
| 其他品种(元) | 4,019,913.00 | 5,384,594.03 | 2,206,979.11 | 8,348,801.05 | 3,416,234.73 |
| 毛利(元) | |||||
| 脉血康胶囊(元) | 38,758,841.87 | 374,358,724.72 | 164,394,208.41 | 368,354,380.95 | 182,526,151.46 |
| 脉血康片剂(元) | -1,677,114.70 | 10,144,188.13 | 4,071,077.91 | 11,017,847.37 | 5,747,859.57 |
| 晕痛定胶囊(元) | 16,459,412.38 | 43,055,383.70 | 21,317,485.38 | 59,690,985.36 | 30,595,495.52 |
| 其他品种(元) | 33,154,979.84 | 8,768,505.59 | 3,046,765.02 | 10,427,440.55 | 3,368,964.57 |
| 毛利率(%) | |||||
| 脉血康胶囊(%) | 45.69 | 81.95 | 81.20 | 78.84 | 76.48 |
| 脉血康片剂(%) | -62.67 | 61.54 | 65.47 | 78.06 | 76.48 |
| 晕痛定胶囊(%) | 75.90 | 75.98 | 75.51 | 78.34 | 80.32 |
| 其他品种(%) | 89.19 | 61.95 | 57.99 | 55.54 | 49.65 |
| 收入构成(%) | |||||
| 脉血康胶囊(%) | 57.96 | 83.96 | 83.60 | 81.07 | 82.00 |
| 脉血康片剂(%) | 1.83 | 3.03 | 2.57 | 2.45 | 2.58 |
| 晕痛定胶囊(%) | 14.82 | 10.41 | 11.66 | 13.22 | 13.09 |
| 其他品种(%) | 25.40 | 2.60 | 2.17 | 3.26 | 2.33 |
| 毛利构成(%) | |||||
| 脉血康胶囊(%) | 44.71 | 85.80 | 85.25 | 81.95 | 82.13 |
| 脉血康片剂(%) | -1.93 | 2.32 | 2.11 | 2.45 | 2.59 |
| 晕痛定胶囊(%) | 18.99 | 9.87 | 11.06 | 13.28 | 13.77 |
| 其他品种(%) | 38.24 | 2.01 | 1.58 | 2.32 | 1.52 |